| Entry |
|
|---|
| Name |
Arsenic trioxide (JP16/USAN);
Trisenox (TN)
|
|---|
| Product |
|
|---|
| Formula |
2As. 3O
|
|---|
| Exact mass |
197.8279
|
|---|
| Mol weight |
197.8414
|
|---|
| Structure |
     |
|---|
| Activity |
Treatment of acute promyelocytic leukemia (APL)
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Interaction |
Genomic biomarker: PML-RARalpha fusion gene [HSA: 5371 5914]
 |
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D02106 Arsenic trioxide (JP16/USAN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX27 Arsenic trioxide
D02106 Arsenic trioxide (JP16/USAN)
Antineoplastics [BR:br08308]
Miscellaneous agents
Salt
Arsenic trioxide [ATC:L01XX27]
D02106 Arsenic trioxide (JP16/USAN)
 |
|---|
| Other DBs |
CAS: 1327-53-3 PubChem: DrugBank: NIKKAJI: |
|---|
| KCF data |
ATOM 5
1 Z As 24.0100 -17.1267 #3+
2 O0 O 29.1900 -17.0800 #2-
3 Z As 24.0100 -17.1267 #3+
4 O0 O 29.1900 -17.0800 #2-
5 O0 O 29.1900 -17.0800 #2-
BOND 0
BRACKET 1 23.2400 -17.9200 23.2400 -16.1700
1 25.8300 -16.1700 25.8300 -17.9200
1 2
ORIGINAL 1 1
REPEAT 1 3
2 27.9300 -17.7800 27.9300 -16.0300
2 30.5200 -16.0300 30.5200 -17.7800
2 3
ORIGINAL 2 2
REPEAT 2 4 5
|
|---|
